Your browser doesn't support javascript.
loading
Telmisartan and esculetin combination ameliorates type 2 diabetic cardiomyopathy by reversal of H3, H2A, and H2B histone modifications.
Kadakol, Almesh; Malek, Vajir; Goru, Santosh Kumar; Pandey, Anuradha; Gaikwad, Anil Bhanudas.
Afiliación
  • Kadakol A; Department of Pharmacy, Laboratory of Molecular Pharmacology, Birla Institute of Technology and Science, Pilani Campus, Pilani, Rajasthan, India.
  • Malek V; Department of Pharmacy, Laboratory of Molecular Pharmacology, Birla Institute of Technology and Science, Pilani Campus, Pilani, Rajasthan, India.
  • Goru SK; Department of Pharmacy, Laboratory of Molecular Pharmacology, Birla Institute of Technology and Science, Pilani Campus, Pilani, Rajasthan, India.
  • Pandey A; Department of Pharmacy, Laboratory of Molecular Pharmacology, Birla Institute of Technology and Science, Pilani Campus, Pilani, Rajasthan, India.
  • Gaikwad AB; Department of Pharmacy, Laboratory of Molecular Pharmacology, Birla Institute of Technology and Science, Pilani Campus, Pilani, Rajasthan, India.
Indian J Pharmacol ; 49(5): 348-356, 2017.
Article en En | MEDLINE | ID: mdl-29515275

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Umbeliferonas / Bencimidazoles / Benzoatos / Diabetes Mellitus Tipo 2 / Cardiomiopatías Diabéticas Límite: Animals Idioma: En Revista: Indian J Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Umbeliferonas / Bencimidazoles / Benzoatos / Diabetes Mellitus Tipo 2 / Cardiomiopatías Diabéticas Límite: Animals Idioma: En Revista: Indian J Pharmacol Año: 2017 Tipo del documento: Article País de afiliación: India Pais de publicación: India